Aldatu Biosciences


Aldatu Biosciences is a biotechnology company dedicated to developing molecular diagnostic assays based on real-time PCR technology. Their mission is to advance infectious disease diagnostics that facilitate society’s response to global health emergencies. They have established the PANDAA platform, a proprietary technology enabling target detection in highly variable genomic regions, which allows for fast, reliable, and cost-effective diagnostic tests for infectious diseases. The company focuses on diseases such as HIV, Lassa fever, Crimean-Congo Hemorrhagic Fever, Ebola, Marburg, Yellow Fever, and SARS-CoV-2, among others. They aim to improve patient healthcare access and outcomes through high-throughput, low-cost diagnostics. Aldatu Biosciences is committed to serving global health needs as a public benefit corporation.

Industries

biotechnology
health-care
medical

Nr. of Employees

small (1-50)

Aldatu Biosciences

Watertown, Massachusetts, United States, North America


Products

Pan-lineage filovirus detection kit (adaptive PCR)

Diagnostic kit designed for universal detection/differentiation of filoviruses using an adaptive PCR approach to account for sequence diversity across lineages.

Focused HIV drug-resistance genotyping kit (adaptive PCR)

Modular genotyping kit for detection of a selected panel of HIV drug resistance mutations across integrase, protease and reverse transcriptase regions using adaptive PCR and PreAmp workflows; kit sizing supports multiple patient samples per run.

SARS-CoV-2 detection and variant genotyping kits (adaptive PCR)

RT-qPCR kits for detection of SARS-CoV-2 and for variant genotyping that are designed to remain effective despite emerging viral mutations using adaptive PCR methods.

Pan-lineage Lassa and CCHF detection kits (adaptive PCR)

Diagnostic kits for universal detection of Lassa virus and Crimean-Congo hemorrhagic fever virus using adaptive PCR approaches to account for lineage diversity.

Hot-start reverse transcriptase formulation

Enzyme reagent optimized for RT-PCR workflows that supports hot-start performance.


Services

Clinical RT-qPCR testing (CLIA-certified laboratory)

High-complexity molecular testing services with sample pickup and rapid turnaround times for hospitals, employers, and institutions; testing uses adaptive PCR-based assays designed for variant robustness.

Collaborative assay evaluation and training programs

Distribution of evaluation and training kits, virtual or in-person training, and support for collaborative validation studies integrating kit use into existing laboratory workflows.

Expertise Areas

  • Molecular diagnostics (RT-qPCR)
  • Focused genotyping for drug resistance
  • Infectious disease and outbreak diagnostics
  • Assay development and analytical validation
  • Show More (5)

Key Technologies

  • Adaptive PCR for sequence-diverse targets
  • Real-time quantitative RT-PCR (RT-qPCR)
  • Targeted genotyping of drug-resistance mutations
  • RT-PCR Pre-amplification (PreAmp) for low-copy RNA
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.